https://www.selleckchem.com/pr....oducts/ll37-human.ht
028). Olfactory bulb 3D T2 FLAIR signal intensity was greater in the patients with COVID-19 and neurologic symptoms compared with an age-matched control group with olfactory dysfunction, and this was qualitatively apparent in 4 of 12 patients with COVID-19. Analysis of these preliminary finding suggests that olfactory apparatus vulnerability to COVID-19 might be supported on conventional neuroimaging and may serve as a noninvasive biomarker of infection. Olfactory bulb 3D T2 FLAIR signal intensity was greater in the patients with COV
Like
Comment
Share
